Telaleaf Health Inc. and Vayamed a Division ofSanity Group Launch Exclusive Partnership
Berlin, Germany, February 08, 2022 —Telaleaf Health Inc. (or “Telaleaf”), a pioneer in cannabis-based telemedicine,today announced an exclusive partnership with Berlin-based medical cannabisspecialist Vayamed, subsidiary of Sanity Group, that will provide increasedaccess to medical cannabis to patients in Germany, as well as education andtraining programs to doctors on the prescription and treatment of cannabismedicines.
Telaleaf, a telemedicinestart-up transforming the access and delivery of medical cannabis care topatients, and medical cannabis brand Vayamed, subsidiary of Sanity Group,are pleased to announce a strategic partnership to improve access to medicalcannabis care to patients in Germany. This exclusive partnership is focused onthe use of telemedicine to strengthen the delivery of cannabis-based treatmentsthrough premier clinical care, better access, superior treatment quality,individualized treatment plans and patient-centered pricing. The partnership isalso focused on delivering academic and clinical-level training and educationto doctors, pharmacists and other relevant practitioners.
Telaleaf is a pioneer in cannabis-based telemedicine from Canadaestablished in 2020 that allows patients to book virtual medical visits withcannabis-trained doctors and is now launching its web and mobile app in theGerman healthcare system. The app provides a first-of-its kind, end-to-endtelemedicine experience for receiving personalized cannabis care from topspecialists, such as world-renown cannabis medicine pioneer, FranjoGrotenhermen, M.D.
Vayamed and Telaleaf are driven by the vision that telemedicinewill continue to move healthcare delivery from clinic to home, and will becomethe standard in the delivery of cannabis-based medicine. Doctor visits toconsult about Vayamed products and treatment options are planned as well asfurther programs in the field of talent support and expert training at leadingmedical faculties nationwide.
"The importance of telemedicine in the German healthcaresystem will continue to grow. It offers many benefits for doctors, patients andthe healthcare system, for example better access and treatment quality,qualified trainings, and improved health insurance reimbursement levels throughspecial training offers for doctors. Together with Telaleaf, we want to improvetherapies with medical cannabis in Germany through the utilization oftelemedicine," said Thimo V. Schmitt-Lord, Director New Markets &Innovation at Vayamed.
“In order to fully realize the vision of cannabis-based medicineas the advanced, alternative medicinal modality it has proven to be, Telaleafhas entirely reimagined the cannabis healthcare delivery model such that allnecessary medical services, tools and resources come together for patients anddoctors under one unified field. Our joint mission with Vayamed is to drivebetter health outcomes for patients with personalized virtual care that issustained by expert-led medicinal cannabis training and education,” saidTelaleaf CEO, Gavin Treanor.
Telaleaf collaborates with leading experts such as Prof. KirstenMüller-Vahl, M.D., and Franjo Grothenhermen, M.D., by whom medical cannabistraining for participating doctors is instructed at the highest educationallevel, in cooperation with Dresden International University.
Medical cannabis specialist Vayamed, a brand of Berlin-basedhealth and life science company Sanity Group, specializes in the developmentand distribution of innovative cannabinoid-based medicinal products for theEuropean market and, as a reliable provider, is committed to making medicalcannabis accessible to doctors, pharmacists and patients.
About Sanity Group
Sanity Group, a Berlin-based health and life-science company, aimsto improve people’s quality of life through the use of cannabinoids and theutilization of the endocannabinoid system. The focus is on pharmaceuticals andmedical products (Sanity Medical) on the one hand and cannabinoid-basedconsumer goods (Sanity Care) on the other. The mission is to build the leadingcannabinoid company for medical cannabis and consumer health in Europe.Financially and strategically, Sanity Group is supported by investors such asRedalpine, HV Capital, Calyx, Casa Verde Capital, Navy Capital, CherryVentures, SOJE Capital, Bitburger Ventures, and various business angels such asmusic producer Will.i.am, Hollywood actor Alyssa Milano, professional soccerplayer Mario Götze and German model Stefanie Giesinger.
About Telaleaf Health Inc.
Telaleaf is a telemedicine company transforming the delivery ofcannabis care by connecting patients to expert doctors, trained incannabis-based medicine, who conduct virtual medical visits and providepersonalized treatment plans. Our aim is to improve patient outcomes, byimproving the patient experience with high quality treatment, ease of access,and expert-led training to practitioners, for the most advanced virtual care incannabis medicine.